Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 7 minute read Pharma Industry News Genfit abandons VS-01 in ACLF after safety scare—can a pivot to UCD rescue GNFT’s pipeline story? Genfit ends VS-01 in ACLF and refocuses on UCD, trims spend, and extends runway beyond 2028. Find out what it means for GNFT stock and 2025 catalysts. byPallavi MadhirajuSeptember 21, 2025